# Venture Global, Inc.: financial statements, quarterly

VG · NYSE · CIK 2007855 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vg.md) · [Financials](/companies/vg/financials.md) · [Filings](/companies/vg/filings.md) · [Insiders](/companies/vg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vg/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,414](/filings/0002007855-25-000018.md) | [1,108](/filings/0002007855-25-000042.md) | [926](/filings/0002007855-25-000066.md) | [1,524 d](/filings/0002007855-26-000013.md) | [2,894](/filings/0002007855-26-000040.md) | [3,101](/filings/0002007855-26-000062.md) | [3,329](/filings/0002007855-25-000066.md) | [4,445 d](/filings/0002007855-26-000013.md) | [4,599](/filings/0002007855-26-000040.md) | [4,578](/filings/0002007855-26-000062.md) |
| Research and development | $m | [181](/filings/0002007855-25-000018.md) | [174](/filings/0002007855-25-000042.md) | [156](/filings/0002007855-25-000066.md) | [124 d](/filings/0002007855-26-000013.md) | [182](/filings/0002007855-26-000040.md) | [57.0](/filings/0002007855-26-000062.md) | [53.0](/filings/0002007855-25-000066.md) | [52.0 d](/filings/0002007855-26-000013.md) | [46.0](/filings/0002007855-26-000040.md) | [23.0](/filings/0002007855-26-000062.md) |
| Operating income | $m | [617](/filings/0002007855-25-000018.md) | [363](/filings/0002007855-25-000042.md) | [189](/filings/0002007855-25-000066.md) | [594 d](/filings/0002007855-26-000013.md) | [1,080](/filings/0002007855-26-000040.md) | [1,038](/filings/0002007855-26-000062.md) | [1,320](/filings/0002007855-25-000066.md) | [1,718 d](/filings/0002007855-26-000013.md) | [1,151](/filings/0002007855-26-000040.md) | [2,188](/filings/0002007855-26-000062.md) |
| Interest expense | $m | [186](/filings/0002007855-25-000018.md) | [153](/filings/0002007855-25-000042.md) | [128](/filings/0002007855-25-000066.md) | [117 d](/filings/0002007855-26-000013.md) | [276](/filings/0002007855-26-000040.md) | [310](/filings/0002007855-26-000062.md) | [421](/filings/0002007855-25-000066.md) | [447 d](/filings/0002007855-26-000013.md) | [444](/filings/0002007855-26-000040.md) | [489](/filings/0002007855-26-000062.md) |
| Income tax | $m | [175](/filings/0002007855-25-000018.md) | [92.0](/filings/0002007855-25-000042.md) | [(78.0)](/filings/0002007855-25-000066.md) | [248 d](/filings/0002007855-26-000013.md) | [151](/filings/0002007855-26-000040.md) | [116](/filings/0002007855-26-000062.md) | [87.0](/filings/0002007855-25-000066.md) | [276 d](/filings/0002007855-26-000013.md) | [111](/filings/0002007855-26-000040.md) | [336](/filings/0002007855-26-000062.md) |
| Net income | $m | [698](/filings/0002007855-25-000018.md) | [352](/filings/0002007855-25-000042.md) | [(294)](/filings/0002007855-25-000066.md) | [990 d](/filings/0002007855-26-000013.md) | [517](/filings/0002007855-26-000040.md) | [475](/filings/0002007855-26-000062.md) | [550](/filings/0002007855-25-000066.md) | [1,191 d](/filings/0002007855-26-000013.md) | [625](/filings/0002007855-26-000040.md) | [1,417](/filings/0002007855-26-000062.md) |
| Diluted EPS | $ per share | [0.25](/filings/0002007855-25-000018.md) | [0.12](/filings/0002007855-25-000042.md) | [(0.15)](/filings/0002007855-25-000066.md) | not reported | [0.15](/filings/0002007855-26-000040.md) | [0.14](/filings/0002007855-26-000062.md) | [0.16](/filings/0002007855-25-000066.md) | not reported | [0.19](/filings/0002007855-26-000040.md) | [0.51](/filings/0002007855-26-000062.md) |
| Basic EPS | $ per share | [0.28](/filings/0002007855-25-000018.md) | [0.13](/filings/0002007855-25-000042.md) | [(0.15)](/filings/0002007855-25-000066.md) | not reported | [0.17](/filings/0002007855-26-000040.md) | [0.15](/filings/0002007855-26-000062.md) | [0.18](/filings/0002007855-25-000066.md) | not reported | [0.20](/filings/0002007855-26-000040.md) | [0.54](/filings/0002007855-26-000062.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.6](/filings/0002007855-26-000013.md) | [3.6](/filings/0002007855-25-000018.md) | [2.2](/filings/0002007855-25-000042.md) | [1.9](/filings/0002007855-25-000066.md) | [2.4](/filings/0002007855-26-000062.md) | [1.6](/filings/0002007855-26-000040.md) | [3.1](/filings/0002007855-26-000062.md) |
| Current assets | $bn | [4.6](/filings/0002007855-26-000013.md) | [4.9](/filings/0002007855-25-000018.md) | [4.0](/filings/0002007855-25-000042.md) | [3.3](/filings/0002007855-25-000066.md) | [4.0](/filings/0002007855-26-000062.md) | [3.2](/filings/0002007855-26-000040.md) | [4.5](/filings/0002007855-26-000062.md) |
| Total assets | $bn | [43.5](/filings/0002007855-26-000013.md) | [45.1](/filings/0002007855-25-000018.md) | [46.5](/filings/0002007855-25-000042.md) | [50.1](/filings/0002007855-25-000066.md) | [53.4](/filings/0002007855-26-000062.md) | [56.3](/filings/0002007855-26-000040.md) | [61.5](/filings/0002007855-26-000062.md) |
| Current liabilities | $bn | [3.5](/filings/0002007855-26-000013.md) | [2.8](/filings/0002007855-25-000018.md) | [2.9](/filings/0002007855-25-000042.md) | [3.9](/filings/0002007855-25-000066.md) | [4.3](/filings/0002007855-26-000062.md) | [3.7](/filings/0002007855-26-000040.md) | [3.8](/filings/0002007855-26-000062.md) |
| Total liabilities | $bn | [35.6](/filings/0002007855-26-000013.md) | [35.1](/filings/0002007855-25-000018.md) | [36.1](/filings/0002007855-25-000042.md) | [39.3](/filings/0002007855-25-000066.md) | [41.5](/filings/0002007855-26-000062.md) | [44.0](/filings/0002007855-26-000040.md) | [49.4](/filings/0002007855-26-000062.md) |
| Long-term debt | $bn | [29.1](/filings/0002007855-26-000013.md) | [29.1](/filings/0002007855-25-000018.md) | [29.8](/filings/0002007855-25-000042.md) | [31.7](/filings/0002007855-25-000066.md) | [33.4](/filings/0002007855-26-000062.md) | [36.5](/filings/0002007855-26-000040.md) | [41.5](/filings/0002007855-26-000062.md) |
| Current portion of debt | $bn | [0.2](/filings/0002007855-26-000013.md) | [0.2](/filings/0002007855-25-000018.md) | [0.2](/filings/0002007855-25-000042.md) | [0.9](/filings/0002007855-25-000066.md) | [0.8](/filings/0002007855-26-000062.md) | [0.1](/filings/0002007855-26-000040.md) | [0.3](/filings/0002007855-26-000062.md) |
| Shareholders' equity | $bn | [2.9](/filings/0002007855-26-000013.md) | [4.9](/filings/0002007855-25-000018.md) | [5.3](/filings/0002007855-25-000042.md) | [5.7](/filings/0002007855-25-000066.md) | [6.7](/filings/0002007855-26-000062.md) | [7.2](/filings/0002007855-26-000040.md) | [8.6](/filings/0002007855-26-000062.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [638](/filings/0002007855-25-000018.md) | [558 d](/filings/0002007855-25-000042.md) | [280 d](/filings/0002007855-25-000066.md) | [673 d](/filings/0002007855-26-000013.md) | [1,114](/filings/0002007855-26-000040.md) | [1,458 d](/filings/0002007855-26-000062.md) | [1,883 d](/filings/0002007855-25-000066.md) | [2,111 d](/filings/0002007855-26-000013.md) | [763](/filings/0002007855-26-000040.md) | [2,072 d](/filings/0002007855-26-000062.md) |
| Capital expenditure | $m | [3,004](/filings/0002007855-25-000018.md) | [3,251 d](/filings/0002007855-25-000042.md) | [3,803 d](/filings/0002007855-25-000066.md) | [3,659 d](/filings/0002007855-26-000013.md) | [3,466](/filings/0002007855-26-000040.md) | [2,980 d](/filings/0002007855-26-000062.md) | [3,294 d](/filings/0002007855-25-000066.md) | [3,625 d](/filings/0002007855-26-000013.md) | [3,181](/filings/0002007855-26-000040.md) | [3,719 d](/filings/0002007855-26-000062.md) |
| Dividends paid | $m | [15.0](/filings/0002007855-25-000018.md) | [14.0 d](/filings/0002007855-25-000042.md) | [54.0 d](/filings/0002007855-25-000066.md) | [56.0 d](/filings/0002007855-26-000013.md) | [190](/filings/0002007855-26-000040.md) | [(190) d](/filings/0002007855-26-000062.md) | [423 d](/filings/0002007855-25-000066.md) | [42.0 d](/filings/0002007855-26-000013.md) | [180](/filings/0002007855-26-000040.md) | [(91.0) d](/filings/0002007855-26-000062.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2,581](/filings/0002007855-25-000018.md) | [2,576](/filings/0002007855-25-000042.md) | [2,350](/filings/0002007855-25-000066.md) | [2,643](/filings/0002007855-26-000040.md) | [2,635](/filings/0002007855-26-000062.md) | [2,641](/filings/0002007855-25-000066.md) | [2,635](/filings/0002007855-26-000040.md) | [2,643](/filings/0002007855-26-000062.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.